文献库，生知库 | 链接生命科学的每一步

日期影响因子

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline.

SARS-CoV-2 病毒与胆碱能系统：刺突蛋白与人类尼古丁乙酰胆碱受体和尼古丁激动剂伐尼克兰的相互作用

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms24065597

Carlson Eric C, Macsai Marian, Bertrand Sonia, Bertrand Daniel, Nau Jeffrey

发表日期：2023

文献求助收藏

OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2

OC-01（伐尼克兰溶液）鼻喷雾剂治疗自身免疫性疾病患者的干眼症体征和症状：来自 ONSET-1 和 ONSET-2 的综合数据

doi:10.2147/OPTH.S403953

Schallhorn, Julie M; McGee, Selina; Nau, Jeffrey; Macsai, Marian; Gibson, Andrea; Blemker, Gretchen; Hendrix, Laura H; Massaro-Giordano, Mina

自身免疫性疾病

免疫/内分泌

发表日期：2023

文献求助收藏

A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease

单次使用OC-01（伐尼克兰溶液）鼻喷雾剂可引起干眼症患者结膜杯状细胞的短期改变

期刊:Ophthalmology and Therapy

影响因子:3.2

doi:10.1007/s40123-022-00530-x

Dieckmann, Gabriela M; Cox, Stephanie M; Lopez, Maria J; Ozmen, M Cuneyt; Yavuz Saricay, Leyla; Bayrakutar, Betul N; Binotti, William W; Henry, Eugenia; Nau, Jeffrey; Hamrah, Pedram

细胞生物学

发表日期：2022

文献求助收藏

ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

ONSET-1 2b期随机试验，旨在评估OC-01（伐尼克兰溶液）鼻喷雾剂对干眼症体征和症状的安全性和有效性

影响因子:2.1

doi:10.1097/ICO.0000000000002941

Wirta, David; Torkildsen, Gail L; Boehmer, Blair; Hollander, David A; Bendert, Edward; Zeng, Lijuan; Ackermann, Michael; Nau, Jeffrey

发表日期：2022

文献求助收藏